COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NEW ZEALAND

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Natural Trend Hits Cough, Cold and Allergy Remedies

Preventive Measures on the Rise

Increased Segmentation

Competitive Landscape

Reckitt Benckiser Remains the Leader

Brands Expanding Their Portfolios

Category Data

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018

Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018

Table 3 Sales of Decongestants by Category: Value 2013-2018

Table 4 Sales of Decongestants by Category: % Value Growth 2013-2018

Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018

Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018

Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023

Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023

Executive Summary

Move Towards Preventive Medicine Continues

Herbal/natural Trend Continues

Companies Strengthening Positions

Discount Pharmacies Increasing Presence

Future of Consumer Health in New Zealand

Market Indicators

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 10 Life Expectancy at Birth 2013-2018

Market Data

Table 11 Sales of Consumer Health by Category: Value 2013-2018

Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format: % Value 2013-2018

Table 17 Distribution of Consumer Health by Format and Category: % Value 2018

Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Sources

Summary 2 Research Sources

An increasing number of natural products have appeared in cough, cold and flu remedies aisles in most retailers. Speciality stores and supermarkets in particular have seen an increase in the presence of herbal products. Consumers prefer a combination of resting and using natural resources such as honey and hot water to combat colds and flus. This trend has given rise to new products such as Cof-Ex by Comvita, which is a combination of olive leaf extract, manuka honey and propolis.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.